2019年度国家自然科学基金临床肿瘤研究方向分析及思考  

Analysis and reflection on the research directions of clinical oncology projects of National Natural Science Foundation of China in 2019

作　　者：宋永喜 冯玉宽[1,3] 洪雪辉 金雅琼[1,5] 戴洁 陈怡文[1,7] 蔺志杰 夏庆华[1,9] 刘莹 吕群燕 Yongxi Song;Yukuan Feng;Xuehui Hong;Yaqiong Jin;Jie Dai;Yiwen Chen;Zhijie Lin;Qinghua Xia;Ying Liu;Qunyan Lv(Department of Health Sciences,National Natural Science Foundation of China,Beijing 100085,China;Department of Surgical Oncology,First Hospital of China Medical University,Shenyang 110001,China;Heilongjiang Province for Cancer Prevention and Control,Mudanjiang Medical University,Mudanjiang 157011,China;Department of Gastrointestinal Surgery,Zhongshan Hospital of Xiamen University,Xiamen 361004,China;Beijing Children's Hospital,Capital Medical University,Beijing 100045,China;Department of Thoracic Surgery,Shanghai Pulmonary Hospital,Tongji University,Shanghai 200433,China;Department of HBP Surgery,First Affiliated Hospital of Zhejiang University,School of Medicine,Hangzhou 310000,China;Department of Immunology,Medical College,Yangzhou University,Yangzhou 225001,China;Department of Urology,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250014,China;School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,China)

机构地区：[1]国家自然科学基金委员会医学科学部,北京市100085 [2]中国医科大学附属第一医院胃肠肿瘤外科 [3]牡丹江医学院黑龙江省肿瘤疾病防治重点实验室 [4]厦门大学附属中山医院胃肠外科 [5]首都医科大学附属北京儿童医院 [6]同济大学附属上海市肺科医院 [7]浙江大学医学院附属第一医院肝胆胰外科 [8]扬州大学医学院免疫学教研室 [9]山东第一医科大学附属省立医院泌尿外科 [10]湖北医药学院基础医学院

出　　处：《中国肿瘤临床》2020年第4期202-207,共6页Chinese Journal of Clinical Oncology

摘　　要：随着细胞生物学等学科的不断发展和深入,肿瘤学基础研究取得了一定进展,肿瘤学科申请项目数量及质量也逐渐提高。本文总结2019年度国家自然科学基金临床肿瘤学科面上项目、青年科学基金项目以及地区科学基金项目的申请与资助情况,并从不同角度深入分析面上项目的研究方向,针对临床肿瘤中非编码RNA、肿瘤免疫治疗、肿瘤微环境、肿瘤代谢等代表性研究方向,以及淋巴管新生、细胞焦亡及铁死亡、溶酶体及线粒体等研究前沿进行综述。Owing to the developments in cell biology and other related disciplines,basic oncological research has progressed.There has been a gradual increase in the quantity and quality of research applications for oncology.This paper provided an overview of the applications and fundings(General Program,Youth Program and Regional Program)for clinical oncology of the National Natural Science Foundation of China in 2019,analyzed the research directions of the General Program from different perspectives and discussed representative research directions including non-coding RNA,immunotherapy,microenvironment,metabolism,as well as frontiers such as lymphangiogenesis,pyroptosis and ferroptosis,lysosome and mitochondrion in the field of clinical oncology.

关 键 词：国家自然科学基金 临床肿瘤 研究方向 数据分析 

分 类 号：R73-3[医药卫生—肿瘤]